#immunogenomics — Tuesday, June 16, 2026 (1 items)
| 0 | ℹ |
Biomarker study of pembrolizumab in patients with advanced rare cancers.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-06-16 | #cancer #immunotherapy #biomarker #immunogenomics #tumor microenvironment |